Generating PDF document
Please, wait a moment
Too much time loading?
Reload the page and try again.
Please, wait a moment
Too much time loading?
Reload the page and try again.
Description
The lines of work defined in the preclinical advanced therapies area are structured around three areas: Cellular: Clinical trial: Tissue engineering: Biomaterials. Gene therapy. The purpose of these lines of work is to provide solutions to problems not solved by current advances in retinal pathologies. The outlined objectives are as follows: Development and improvement of experimental models (animal models, cell cultures and organotypical cultures) adapted to early prediction models and risk minimization. Research focused on the knowledge of pathogenic processes involved in some retinal pathologies in order to identify new risk biomarkers and new therapeutic targets. Development of observational and experimental studies.Other information
Number of researchers:
2
Development status:
In research and development phase
Differentiation in the market:
Quality
Applicability of technology:
Yes
Companies and markets:
BIO companies, Farmas and other companies in the field of ophthalmic sciences.
Advantages:
The staff involved have extensive experience in the development of models (animal models, cell cultures and organotypical cultures) for research in the ophthalmology field. Advanced therapies: Transplantation of mesenchymal stem cells for the treatment of retinal degeneration and optic nerve diseases. Development of experimental models for research in the ophthalmology field. The characterized models are considered suitable for drug testing. Identification of genetic risk factors.
Additional Information:
Certificate of Good Laboratory Practice (GLP) by the Spanish medical products agency for the in vitro/in vivo clinical use.
UNESCO Code:
2403 - Biochemistry
Other members:
Iván Fernández Bueno
The objective of the UVa Retina Research Group is to solve current problems of retinal pathologies that still lack solution:Identify risk factors.Study the pathogenesis.Propose new therapeutic targets in retinal pathologies.Objectives:Creation of mul... Read more >
ObjectivesThe main purpose of the group is the research and development of new recombinant systems of protein origin and their application for the experimental therapy of diseases (Nanomedicine). Another purpose of the group is to assist and advise o... Read more >
The University of Valladolid’s Institute of Applied Ophthalmo-Biology (IOBA), in collaboration with the Department of Medicine, Surgery and Veterinary Anatomy of the University of León, offers its services to companies or scientific groups for the... Read more >
PURPOSE OF THE GROUP. Increase the efficiency of the current systems used in the reconstruction of the ocular surface inflammation (allergy, dry eye and others), both with medical means (new drugs, nanotechnology) and surgical means (tissue engi... Read more >
